Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), Physician- and Patient-Rated Global Assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials-Reference-Cited by-同舟云学术

Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), Physician- and Patient-Rated Global Assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials

Published:2011-11 Issue:S11 Volume:63 Page:S98-S111
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Pope Janet

Publisher

Wiley

Subject

Rheumatology

Reference99 articles.

1. Development of a provisional core set of response measures for clinical trials of systemic sclerosis;Khanna;Ann Rheum Dis,2008

2. Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS);Khanna;J Rheumatol,2009

3. Measurement of patient outcome in arthritis;Fries;Arthritis Rheum,1980

4. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time;Steen;Arthritis Rheum,1997

5. Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument;Khanna;Arthritis Rheum,2009

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease;Journal of Clinical Oncology;2024-08-16

2. Patient-reported outcomes in HSCT for autoimmune diseases: Considerations on behalf of the EBMT ADWP, PAC, and Nurses Group;Journal of Allergy and Clinical Immunology: Global;2024-08

3. The Use of “Acellbia”—A Biosimilar of Rituximab in Systemic Sclerosis;Doklady Biochemistry and Biophysics;2024-06-10

4. Severity and impact of digestive impairment perceived by patients with systemic sclerosis: a cross-sectional study;BMJ Open;2024-04

5. Predictors and prognosis of pulmonary hypertension complicating interstitial lung disease in systemic sclerosis;Rheumatology;2024-03-12